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Abstract 
Satellite cells (SCs) are adult muscle stem cells capable of repairing damaged and creating new 
muscle tissue throughout life. Their functionality is tightly controlled by a microenvironment 
composed of a wide variety of factors, such as numerous secreted molecules and different cell 
types, including blood vessels, oxygen, hormones, motor neurons, immune cells, cytokines, 
fibroblasts, growth factors, myofibers, myofiber metabolism, the extracellular matrix and tissue 
stiffness. This complex niche controls SC biology – quiescence, activation, proliferation, 
differentiation or renewal and return to quiescence. In this review, we attempt to give a brief 
overview of the most important players in the niche and their mutual interaction with SCs. We 
address the importance of the niche to SC behavior under physiological and pathological 
conditions, and finally survey the significance of an artificial niche both for basic and 
translational research purposes. 
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Satellite cells 
Over the past half a century, the focus of research on muscle regeneration has shifted from 
other myogenic cells of muscle tissue to satellite cells (SCs), from developmental myogenesis 
to adult muscle regeneration, from cell-intrinsic properties of SCs to the relevance of extrinsic 
factors delivered by their niche. SCs,  small, inactive cells wedged between the myofiber and 
the surrounding extracellular matrix (ECM), have attracted the attention of scientists since their 
discovery 56 years ago (1). The astonishing translational potential of SCs continues to 
fascinate, and the ever expanding knowledge of SCs and their microenvironment paves the way 
for the development of novel cell and gene therapies, in vitro disease models and preclinical 
drug testing paradigms. Here, we discuss different aspects of SC biology and the niche in health 
and disease. For a more detailed assessment of the particularities of SCs and the SC niche, we 
direct readers to several recent reviews focusing on the extracellular matrix (2), blood vessels 
(3), bioengineering (4), SC function from a cell-intrinsic perspective (5) and an extensive 
review on SC biology (6). 
Skeletal muscle regeneration and muscle stem cells 
Comprising approximately 40% of body weight, skeletal muscle can be considered as the 
largest organ in the human body (7). Muscle not only supports breathing and movement, but is 
also a very important metabolic and endocrine organ. It comes as no surprise that skeletal 
muscle has a remarkable capability to repair damage caused by injuries or simple everyday 
wear-and-tear. As numerous animal studies demonstrate, skeletal muscle is able to regain near 
original morphology and functionality within several weeks of serious damage caused by 
injection of myotoxic agents (e.g. cardiotoxin, bupivacaine, barium chloride or notexin), 
freezing, crushing, or complete mincing and re-transplantation (8-12). However, aging, 
traumatic injuries in humans resulting in volumetric muscle loss and various myopathies result 
in impaired functionality and inability of the tissue to regain homeostatic conditions.  
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SCs are the main cells responsible for sustaining skeletal muscle morphology and functionality 
throughout the lifetime of an individual. They are largely lineage-committed adult stem cells 
located at the periphery of muscle fibers, situated between the sarcolemma (the myofiber 
membrane) and basal lamina (BL) (1), in close proximity to blood vessels (3) and the 
neuromuscular junction (13). This specific environment surrounding SCs is known as the SC 
niche. 
Under resting conditions, SCs are in the G0 phase (non-cycling state) and quiescent, with a 
heterochromatic nucleus and a thin rim of cytoplasm containing scarce organelles. These cells 
are most commonly distinguished by the expression of the paired box transcription factor Pax7. 
SCs have a tremendous myogenic potential and self-renewal capabilities, as demonstrated by 
single-fiber (14) as well as single cell (15) implantation in irradiated muscles of 
immunodeficient mice.  
The classical cascade of regeneration resembles that of prenatal skeletal muscle development 
(16). In response to injury or other stimuli, SCs become activated, increase in size and begin 
proliferation. The majority of the progeny reduces Pax7 and induces MyoD expression. After 
several rounds of proliferation, these myoblasts start to express myogenin and exit the cell 
cycle as myocytes. The myocytes subsequently fuse in order to form new or repair existing 
myofibers (depending on the severity of injury). The myofibers then express MRF-4 and grow, 
supported by hypertrophy, until reaching their pre-injury size. At the same time, a part of the 
SC progeny reacquires high Pax7 levels and returns to quiescence, thereby replenishing the SC 
pool and maintaining sufficient reserves for future rounds of regeneration.  
Besides SCs, several other cell types, such as muscle side population cells, muscle-derived 
stem cells, bone marrow stem cells, PW1+ interstitial cells, CD133+ cells, mesoangioblasts and 
pericytes, can successfully regenerate muscles and some can even reconstitute the niche upon 
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transplantation into damaged muscle (17). However, the contribution of these cells seems to be 
very low under physiological conditions and dependent on SCs, which are essential for skeletal 
muscle regeneration and therefore represent the true stem cells of muscle tissue (18-21). 
According to their gene expression profiles and their characteristics in vitro, SCs stemming 
from different muscle groups (e.g. head vs. limb muscles) are heterogeneous. Nevertheless, 
SCs from the masseter muscle (head) are able to regenerate the extensor digitorum longus 
(EDL) muscle (limb) as efficiently as SCs from the EDL muscle (22), attesting to the enormous 
influence of the in vivo microenvironment on the behavior and functionality of SCs, which in 
some cases can overcome the intrinsic differences between SCs. 
The heterogeneity of satellite cells and its dependence on the niche 
Several studies have addressed the heterogeneity of SC populations in regard to their renewal 
potential. Interestingly, SC heterogeneity was not only reported between different muscle beds, 
but also observed between SCs on the same muscle fibers, thereby implicating additional 
factors besides ontogeny and composition of the fiber type as possible causes. According to 
these studies, only a small proportion of SCs are bona fide stem cells, whereas the vast majority 
are committed progenitors with limited stemness. For example, Chakkalakal et al. discovered 
heterogeneity among SCs based on their proliferative history, suggesting that cells that cycle 
less frequently have higher self-renewal potential (23). On a related note, Rocheteau et al. 
evaluated differential DNA strand segregation, where one daughter cell retains the template 
strands, stays in the niche and returns to quiescence, while the other daughter cell receives 
newly synthesized DNA strands, continues to proliferate and finally differentiates (24). It was 
suggested that such DNA strand segregation would prevent accumulation of proliferation-
associated mutations in the stem cell, and therefore provide a lifelong supply of progenitors. 
Similarly, in a lineage tracing experiment with Myf5-Cre/ROSA-YFP mice, Kuang et al. found 
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that the majority of SCs are Pax7+/Myf5+, and only small subset are Pax7+/Myf5- cells (25). 
Upon isolation and transplantation, both cell populations are capable of proliferating and 
differentiating, but only Myf5- SCs occupy the niche in the transplanted muscle. In addition, 
after in vivo activation, Pax7+/Myf5+ (committed progenitors) are exclusively prone to 
symmetrical division, giving rise to more committed progenitors, whereas Pax7+/Myf5- (true 
stem cells) on the other hand can divide both symmetrically and asymmetrically, producing 
uncommitted and committed daughter cells. Mechanistically, the asymmetrical distribution of 
the Par complex results in p38α/β MAPK activation and MyoD expression only in the 
committed daughter (26). Importantly, the capability to control the orientation of the cell 
division is tightly coupled to the SC niche. Following asymmetric division, the uncommitted 
progenitor remains in the niche in contact with the BL, whereas the committed progenitor is 
pushed towards the muscle fiber, thus losing contact with the niche. In contrast, both daughter 
cells retain contact with the BL and the myofiber during a stem cell pool expansion through 
symmetric division of Pax7+/Myf5- cells. 
The satellite cell niche in quiescence and regeneration 
SC quiescence, activation, proliferation, differentiation and renewal are intricately connected 
to the niche. There is a plethora of cell-cell and cell-matrix interactions, numerous paracrine 
and endocrine molecules (e.g. growth factors and cytokines), as well as biophysical properties 
of muscle that have a direct effect on the SC. However, this communication is bidirectional, as 
the SCs themselves also influence their local environment.  
The extracellular matrix 
In homeostatic conditions, SCs are situated just outside the muscle fiber, in direct contact with 
the sarcolemma and the ECM. The ECM surrounding muscle fibers is called the basal 
membrane (BM) and it consists of two parts – the reticular lamina (RL) and the BL, the latter 
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being in direct contact with the fiber. The BM is a mesh composed of various glycoproteins 
and proteoglycans with sequestered growth factors. The main components of the RL are 
fibrillar collagens, whereas the main components of the BL are laminin-2 (α2β1γ1) and non-
fibrillar collagen IV (27). The laminins and collagen of the BL self-assemble into networks 
that are cross-linked by the glycoprotein nidogen. This network provides binding sites for 
components of the RL on one, and the sarcolemma and SC membrane on the other side. In 
addition, proteoglycans such as perlecan are anchored to the main BL mesh and bind 
polypeptidic growth factors with their glycosaminoglycan chains. These growth factors, 
including fibroblast growth factors (FGFs), epidermal growth factor (EGF), insulin-like growth 
factors (IGFs) and hepatocyte growth factor (HGF), are secreted by various components of the 
niche, such as muscle fibers, interstitial cells and SCs, or can be delivered to the niche by blood 
vessels.  
Integrins on the SC membrane and the sarcolemma bind to laminins in the BL, forming focal 
adhesions and contributing to mechanical stability between the ECM and intracellular 
cytoskeleton. However, these interactions also have important signaling functions. The main 
integrin isoforms on SCs are α7 and β1, which bind to laminin-2 on the BL side (28). After SC 
activation, the expression of integrins on the SC membrane changes, along with the preference 
for binding partners in the BL. For example, activated, but not quiescent SCs express the β3 
integrin isoform, which probably binds to fibronectin in a complex with the αv chain (29). Both 
quiescent and activated SCs also express the transmembrane heparin sulfate proteoglycans 
syndecan-3 and syndecan-4. These proteins form complexes with different tyrosine kinases 
such as c-Met and FGF receptor (FGFR) on the SC membrane and are consequently important 
not only for cell adhesion to the BL, but also for SC activation (30).  
Expression profiles of quiescent and activated SCs suggest that SCs actively contribute to 
maintaining niche quiescence while remaining highly sensitive to activating stimuli (31). 
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Quiescent SCs express the protease inhibitors Serpin and Tfpi2 as well as metalloprotease 
inhibitor Timpf4. Upon activation, however, these genes become downregulated, and instead, 
SCs start expressing the matrix metalloproteases MMP-2 and MMP-9 (32). MMPs are major 
enzymes responsible for ECM degradation.  
Activated SCs also produce fibronectin (FN), an ECM glycoprotein whose role in SC 
maintenance by enabling their attachment to the niche has recently been demonstrated (33). 
SC-produced FN potentiates Wnt7a signaling through the receptor complex syndecan-
4/Frizzled-7, thereby supporting symmetric division of SCs and expansion of the stem cell pool 
(34). Specific knock-down of FN in SCs leads to a drastic reduction in symmetric division, in 
particular in the Pax7+/Myf5- population, leading to a drop in SC numbers during regeneration. 
Collagen VI is another BL component essential for preserving the SC pool. Fibroblasts are the 
prime producers of this protein as well as many other BL components. Collagen VI knock-out 
mice exhibit reduced regeneration and an inability to maintain SC numbers following injury. 
This defect is, however, rescued by transplanting wild-type fibroblasts, demonstrating the 
critical importance of non-SC-autonomous ECM factors in SC maintenance (35). 
The muscle fiber 
On the apical side, SCs are bound to a muscle fiber, and M-cadherin is the main adhesion 
protein supporting the connection between these two cell types. Myofibers are important 
regulators of SC state: for example, myofiber damage or stretch induces nitric oxide (NO) 
synthesis in the BL, which is able to activate MMPs, and through that action liberate ECM-
bound HGF, allowing its binding to the c-Met receptor on SCs. This HGF signaling through c-
Met has been proposed as an initial activation signal for SCs (36).  
SCs are furthermore affected by the Notch and Wnt signaling pathways in regard to quiescence, 
activation, proliferation and differentiation (6). Proof-of-concept was provided in different 
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studies, e.g. by ablation of RBP-Jκ, a downstream mediator of Notch., This ablation leads to 
spontaneous activation and differentiation of SCs without a proliferative phase, precipitating 
depletion of the SC pool and thus indicating that Notch signaling is essential for SC quiescence 
(37, 38). Upon injury, damaged fibers express Delta, a ligand of the Notch receptor, which 
stimulates SC proliferation. In addition, regenerating fibers synthesize Wnt7a, which induces 
SC symmetrical cell division by binding to the Frizzled7 receptor (39).  
In regeneration, myofibers secrete stromal cell-derived factor-1 (SDF-1), which binds to the 
receptor CXCR4 on SCs and induces SC chemoattraction (40). Injured fibers and other cells 
of the niche also secrete FGFs, EGF and IGFs, which further regulate SC proliferation and 
differentiation. For instance, FGF-2 induces proliferation and represses differentiation of 
progenitor cells by binding to the tyrosine kinase FGFR and activating the Ras/MAPK pathway 
(41). Likewise, IGF-II supports proliferation, while the pleiotropic functions of IGF-I include 
stimulation of SC proliferation, differentiation, migration and anti-inflammatory effects on the 
niche (reviewed in (42)). These effects of IGF-I are mediated through several signal 
transduction pathways, all initiated by IGF-I binding to the tyrosine receptor kinase IGF1R. 
The situation is further complicated by the existence of multiple IGF-I isoforms, as well as IGF 
binding proteins (IGFBPs) secreted by activated SCs, whose function is to transport IGFs and 
modulate their half-life (reviewed in (43)). On the other hand, myofibers also secrete myostatin 
(Mstn), a member of the transforming growth factor β (TGF-β) family and negative regulator 
of muscle growth that has been implicated in reducing SC activation and self-renewal (44).  
Much attention has been given to metabolic reprograming of SCs, that is, the effects of the 
metabolism of a SC on its fate (45). Some research proposes that in quiescence, SCs primarily 
rely on fatty acid oxidation (46), whereas upon activation, they increase substrate utilization 
through glycolysis, and finally switch to oxidative phosphorylation during differentiation (47). 
Other studies suggest that activated SCs depend more on oxidative phosphorylation (45, 48, 
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49). It also remains unclear how metabolic substrate utilization in skeletal fibers (the SC niche) 
influences the SC state. Experiments with caloric restriction have suggested that the increased 
fatty acid oxidation and mitochondrial activity in the fiber in this context probably induce SC 
activation through increased oxidative phosphorylation (49).  
Effects of fiber metabolism on SCs are furthermore implied by the observation that resting SC 
numbers are considerably higher in oxidative slow-twitch compared to glycolytic fast-twitch 
myofibers (50). Moreover, a similar difference in SC numbers can be achieved by endurance 
exercise, which promotes a switch from glycolytic to oxidative fibers (51, 52). Although a 
conclusive explanation for the correlation between SC numbers and the oxidative fiber type 
remains elusive, the metabolic properties and the vascularization have been linked to this 
observation. The existence of a denser blood vessel network in slow fibers is of particular 
interest given close vicinity of the majority of SCs to blood vessels (3). However, this simple 
view has recently been challenged. Namely, mice with myofiber-specific overexpression of 
peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α), a nodal modulator of 
oxidative metabolism, exhibit both a switch to oxidative fibers and increased capillarity (53), 
but nevertheless have fewer SCs, albeit with an increased myogenic capacity (54). In fact, in 
regard to most metabolic and contractile traits, PGC-1α transgenic, bona fide oxidative and 
endurance-trained muscles are indistinguishable. Interestingly, the muscle fiber PGC-1α 
transgene affects expression of BM components FN and tenascin-C (54), which might account 
for the increased myogenic potential of the SCs. However, a possible influence of other 
differences in the microenvironment, for instance the increased percentage of M2 macrophages 
in resting conditions in these animals, should not be overlooked (11, 55). Therefore, an 
alternative explanation for the correlation between SC number and fiber type could be a 
difference in ECM organization. For example, the slow soleus muscle has double the amount 
of collagen IV and half the amount of laminin-2 compared to the fast rectus femoris in rats 
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(56). However, the link between SC number and fiber type-specific ECM composition is still 
poorly understood and thus awaits further research. 
Blood vessels, oxygen, (peri)endothelial cells and secreted systemic factors 
The close proximity of SCs and capillaries suggests that blood vessels are an important part of 
the niche. Indeed, the close correlation between a well-developed capillary network and 
successful skeletal muscle regeneration has been demonstrated (57, 58). This is not surprising 
given the fact that a myriad of factors and cells that modify the satellite cell niche, such as 
hormones and monocytes, are delivered by blood vessels. In addition, endothelial cells can 
secrete growth factors (EGF, IGF-I, bFGF) including vascular endothelial growth factor 
(VEGF) and platelet-derived growth factor BB (PDGF-BB), which promote SC proliferation 
(59). Conversely, differentiating myogenic cells also secrete VEGF, thereby stimulating 
angiogenesis (60). Interestingly, peri-endothelial cells, such as smooth muscle cells, secrete 
angiopoietin 1 (Ang1), which regulates the SC state by binding to the Tie-2 receptor that is 
highly expressed in resting SCs. This interaction in turn induces the expression of quiescence 
markers and blocks the expression of differentiation markers in SCs through ERK1/2 signaling 
(61), resulting in a return to quiescence at the end of regeneration. 
A reduction in partial oxygen pressure has also emerged as an essential factor in SC biology. 
Hypoxia is a critical factor for many stem cells, with a strong link between low oxygen levels 
and the undifferentiated cell state (62). Myoblasts cultured under hypoxic conditions show 
increased quiescence and higher self-renewal efficiency upon transplantation in vivo (63). 
Finally, systemic, circulating factors facilitate the adjustment of SCs to distal processes away 
from the niche. For example, calcitonin, a thyroid hormone that is secreted in response to high 
blood calcium levels, is important for SC dormancy and sub-laminar location. It exerts its 
effects by binding to the calcitonin receptor (Calcr), which is expressed by resting, but not by 
13 
 
activated SCs (64). A specific knock-out of Calcr in SCs results in their relocation from the 
niche and loss by apoptosis (65). Likewise, SC-specific knock-out of the androgen receptor, 
which is expressed in this cell population (66), leads to induction of Mstn expression, a fiber-
type switch and a reduction in muscle mass and strength (67).  
Motor neurons, fibroblasts, fibro/adipogenic progenitors and immune cells 
In slow-twitch muscles, SCs are located in close proximity to the neuromuscular junction 
(NMJ) (13), and the difference in SC numbers between slow and fast-twitch fibers is correlated 
with the pattern of neuron firing (50). When denervated, skeletal muscle fibers undergo 
atrophy, to which SCs initially respond with activation and proliferation similar to what is 
observed in damaged muscle, but after several weeks of denervation, SC number declines due 
to loss of proliferative capacity and apoptosis (68, 69). Conversely, it has been shown that 
developing muscle produces neurotrophins, which function as retrograde survival factors for 
the motor neuron (70), and SCs secrete the axonal guidance factor semaphorin 3A with possible 
implications in muscle regeneration (71). Although initially found to have a role in neuron 
survival, neurotrophins are emerging as important modulatory factors for various cell 
populations and tissues including skeletal muscle. For example, nerve growth factor (NGF) is 
expressed by regenerating fibers, which implies its involvement in muscle regeneration. 
Similarly, SC expression of brain-derived neurotrophic factor (BDNF) is important for SC 
maintenance, and consequently affects muscle regeneration (72, 73).  
Fibroblasts contribute to the niche by secreting growth factors and structural components of 
the BL. Temporary thickening of the ECM coupled with an increase in the number of muscle 
tissue fibroblasts is a hallmark of muscle regeneration (74). Furthermore, interactions between 
Tcf4+ fibroblasts and SCs are necessary for successful regeneration. Selective, conditional 
ablation of SCs in Pax7CreERT2/+;R26RDTA/+ mice leads to insufficient proliferation of fibroblasts 
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in the initial phases of regeneration and fibrosis at the later stages, whereas the partial ablation 
of fibroblasts in Tcf4CreERT2/+;R26RDTA/+ mice causes reduced proliferation and precocious 
differentiation of SCs, resulting in a decreased diameter of regenerated muscles and depletion 
of the SC pool (21).  
Skeletal muscle-resident mesenchymal progenitors expressing PDGFRα are known as 
fibro/adipogenic progenitors (FAPs) due to their ability to differentiate into adipocytes and 
fibroblasts (75). In homeostatic conditions, these cells are in close proximity to blood vessels 
(76), and their number quickly rises in the event of muscle damage. FAPs facilitate myofiber 
formation and myoblast differentiation by secreting specific ECM components and cytokines, 
respectively (77). These cells also display the ability to remove necrotic tissue (78), thereby 
supporting muscle regeneration. Interestingly, proper signaling from myotubes and eosinophils 
prevents FAP differentiation into adipocytes (75). 
Immune cells are additional important players in defining the SC niche in regeneration. Some 
of these cells, like tissue macrophages and mast cells, are permanent members of the niche, but 
their importance in modulating the SC microenvironment in quiescence is likely limited. 
However, they take on an active role upon sterile injury, which induces muscle fiber damage 
and necrosis. Resident immune cells react by secreting cytokines and chemokines including 
tumor necrosis factor α (TNF-α), interleukin 6 (IL-6) and macrophage inflammatory protein 2 
(MIP-2), which primarily drive the extravasation of neutrophils (79, 80). Next, neutrophils 
secrete MIP-1α, monocyte chemoattractant protein-1 (MCP-1) and other cytokines attracting 
monocytes from blood vessels, which rapidly become the most abundant inflammatory cell 
type in the damaged tissue (81). Depending on the milieu of inflammatory signals and immune 
cells present in the niche, the macrophages derived from the monocytes can acquire the M1 or 
M2 type. M1 macrophages secrete proinflammatory cytokines (TNF-α, IL-1β) and are 
characteristic of the early post-injury stages. They are essential for the removal of necrotic 
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tissue and promote SC proliferation. Upon clearance of cellular debris, the altered conditions 
in the niche promote an increase in the number of M2 macrophages, which secrete anti-
inflammatory cytokines (IL-4, IGF-I, TGF-β) and support the differentiation stages of 
regeneration (82, 83). Temporal regulation of the inflammatory cascade is crucial in the 
process. For example, suppression of M1 macrophages leads to reduced SC proliferation, 
persistence of necrosis and results in fat and fibrotic tissue accumulation. Likewise, 
suppression of the switch from the M1 to the M2 type negatively affects myogenesis and 
myofiber growth (84-86). In addition to paracrine signaling, macrophages establish direct 
contact with myoblasts and myotubes through cell adhesion interactions (e.g. via VCAM-1-
VLA-4, ICAM-1-LFA-1, PECAM-1-PECAM-1 and CX3CL1-CX3CR1), which prevent 
apoptosis of myogenic cells (87). Apart from innate immunity, cells of the adaptive immune 
system are also central to regulating SC behavior during sterile injury. An instrumental role of 
T regulatory cells in proper SC expansion and muscle regeneration, as well as in the M1 to M2 
macrophage switch after injury has been described (88, 89). 
The biophysical properties of muscle 
Aside from other factors of the niche, rigidity of the microenvironment can profoundly affect 
SC behavior. The elastic stiffness of uninjured skeletal muscle is ~12kPa, and ECM deposition 
during regeneration increases this value (90). SCs can sense and react to this biophysical 
property of the environment through focal adhesions (91). When cultured on rigid plastic dishes 
(~106kPa), SCs quickly lose their quiescence and stemness. Myoblasts cultured on hydrogels 
prefer a substrate stiffness of ~21kPa, while softer (~ 3kPa) and stiffer (~ 80kPa) gels reduce 
their proliferative rate (92). In line, SCs cultured on soft hydrogels that mimic the stiffness of 
natural muscle (12kPa) are able to self-renew and significantly improve their contribution to 
muscle regeneration upon transplantation (93).  
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The satellite cell niche in pathological contexts 
Aging, muscle dystrophies and related pathologies invariably lead to perturbed conditions of 
the SC niche. These changes can cause a reduction or an expansion in the SC pool, 
irresponsiveness to stimuli and therefore a reduced SC activation rate, aberrant proliferation 
and precocious or reduced differentiation, or SC senescence and apoptosis upon activation. For 
example, a disproportion of symmetric and asymmetric SC division might tip the balance 
towards SC loss in aging and a pathological SC expansion with a reduced number of myogenic 
progenitors in dystrophic conditions (94). Irrespective of the dysregulation, the outcome is 
diminished SC regenerative capacity in both contexts.  
Although some of the pathological changes are SC intrinsic, altering the niche can alleviate the 
underlying condition in many cases. Nevertheless, it is difficult to precisely discriminate 
between intrinsic and extrinsic origins of the SC pathology due to the bidirectional signaling 
between SCs and their microenvironment. Importantly, the niche can induce modifications in 
SC properties that can persist even after removal of SCs from the niche, and are hence 
perceived as “intrinsic”.  
The satellite cell niche in aging 
With advanced age, skeletal muscle mass and neuromuscular performance diminishes, a 
condition termed sacropenia. Decreased fiber and motor neuron numbers, reduced fiber size, a 
myofiber switch towards the oxidative type and loss of myonuclei resulting in an increase in 
myonuclear domain size are all common observations in aging, collectively resulting in a 
marked decrease of the efficiency of muscle regeneration (95, 96). The reduction of the SC 
pool has been proposed as an explanation for the underlying condition (51). However, based 
on conflicting results in different studies (97), the prevailing opinion is that a drop in the 
myogenic potential of SCs might be the causative factor of the impaired regenerative capacity.  
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Some changes in the aged niche are precipitated by aberrant signaling. For instance, lack of 
Delta upregulation by injured aged muscles leads to reduced Notch signaling in SCs and hence 
reduced SC proliferation – a phenotype that can be overcome by alternative Notch activation 
(97). Interestingly, experiments with heterochronic, parabiotic pairings (a shared circulatory 
system between a young and an old animal) demonstrated that systemic factors at least partially 
account for the perturbed SC biology, as the exposure to young blood restored otherwise 
reduced Notch signaling and improved SC proliferation in old mice (98). The subsequent 
search for rejuvenating humoral factors led to the implication of the hormone oxytocin (99) 
and growth factor GDF11 (100, 101) as systemic factors that decline with age and whose 
induction is able to revert aging-related SC pathology. However, the function of GDF11 in 
promoting muscle and cardiac health in aging has been largely discredited in more recent 
studies (102-104). Exacerbated canonical Wnt signaling due to elevated circulating Wnt 
activators in aged mice was also suggested as being responsible for aging-related tissue fibrosis 
and conversion of myoblasts into fibroblasts, a process that can be curbed by Wnt inhibitors 
(105). Increased NF-κB and TGF-β signaling in aged muscles are additional examples of how 
the immediate niche can negatively impact the regenerative potential of SCs (106, 107). 
ECM deposition in the aged niche in general is thought to act as a damper and therefore exert 
a negative influence on the activation potential of SCs, e.g. by increasing tissue stiffness. For 
example, slow muscles boost the expression of collagen IV while fast muscles elevate the levels 
of laminin with aging (56). The ensuing imbalance in the components of the BL in old muscle 
disturbs the signal transduction pathways that govern SCs in the niche, such as those triggered 
by higher levels of TGF-β, a negative regular of SC proliferation (107), and FGF-2. FGF2 
signaling through FGFR1 results in SC loss based on unmitigated cycling. Importantly, this 
effect can be reverted by increasing Spry1 in SCs, an inhibitor of FGF signaling and preserver 
of SC quiescence (23). The p38α/β MAPK pathway, downstream of FGF signaling, is 
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consequently overactivated in aged SCs, leading to reduced asymmetric division and higher 
numbers of committed daughter cells, hence resulting in diminished self-renewal. Improving 
the SC environment by transplanting old SCs into a young host could not revert this condition, 
in contrast to the successful pharmacological inhibition of the p38α/β MAPK pathway in SCs 
(108, 109). Most likely triggered by increased IL-6 blood levels, the JAK/STAT signaling 
pathway is also overactivated in aged SCs and results in a reduction of symmetric division and 
self-renewal, which can be reverted with pharmacological inhibitors (110, 111). In geriatric 
mice (30 months of age), SCs lose their ability for reversible quiescence by switching to pre-
senescence. At that age, the respective stimuli fail to induce SC activation and proliferation, 
but instead prompt senescence in a process termed geroconversion. Silencing of p16INK4a, a cell 
cycle inhibitor that triggers the switch to pre-senescence, is able to restore the activation and 
proliferation potential of SCs (112). Intriguingly, blocking autophagy in young SCs causes 
senescence, while its restoration in old age reestablishes the regenerative potential of SCs 
(113). Furthermore, loss of FN from the aged BL prevents sufficient attachment of SCs to the 
niche and thus disturbs signaling through focal adhesion kinase, thereby precipitating SC loss 
(33). In addition, mislocalization of integrin β1 on aged and dystrophic SCs leads to impaired 
sensitivity to FGF-2, consequently causing reduced SC proliferation and ultimately SC 
depletion, resulting in impaired regeneration. In both models, activation of β1-integrin reverts 
the impairment of SC function (114). 
Hormonal and pharmacological interventions, calorie restriction as well as cell therapy have 
been proposed for the prevention and treatment of sarcopenia. However, to date, physical 
activity remains the most efficacious approach to combating this disease (115), e.g. by boosting 
the number and myogenic capacity of SCs (51, 116). Although an SC pathology is most likely 
not the only driving force for development of sacropenia, SC dysfunction contributes to 
impaired muscle regeneration and increased fibrosis (105). Recent advances in understanding 
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aberrant signal transduction pathways and communication between aged SCs and their niche 
will potentially offer new pharmacological avenues in the treatment of sarcopenia that could 
circumvent the inherent problems of exercise interventions in geriatric patients.  
The satellite cell niche in dystrophic conditions 
Muscular dystrophies are a heterogeneous group of sporadic and inherited disorders that lead 
to progressive muscle wasting and weakness. Fiber size variation, fiber necrosis followed by 
inflammation, and muscle tissue replacement by fat and scar tissue are often hallmarks of these 
pathologies, depending on the severity of the dystrophy in question (117). Many dystrophies 
are caused by a mutation in structural proteins of the cytoskeleton, membrane or ECM, which 
comprise a part of the SC niche. 
One of the most common and extensively studied dystrophy is Duchenne muscular dystrophy 
(DMD), which arises due to a genetic mutation in the structural protein dystrophin. Lack of 
dystrophin, a member of the membrane-bound protein complex, leads to the improper 
connection of the cytoskeleton to the ECM, rendering fibers more prone to mechanical damage. 
As a consequence, recurring rounds of degeneration and regeneration form a vicious cycle and 
impose proliferative pressure on SCs. It has been proposed that progressive worsening of the 
disease over time is at least partially due to telomere shortening and ultimately loss of the 
regenerative potential of SCs (118). 
Infiltrating macrophages and T cells induce fibrosis through secretion of pro-fibrotic cytokines, 
which in chronic diseases such as muscular dystrophies result in fibrotic tissue formation at the 
expense of functional muscle tissue (119). For instance, in acute injury, a wave of TNFα-
secreting M1 macrophages induces a reduction of the preceding FAP expansion, thereby 
limiting ECM accumulation. Under chronic conditions, however, loss of proper control of 
macrophage polarization results in exacerbated TGF-β secretion that in turn causes FAP 
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persistence and fibrosis (120). Therefore, anti-inflammatory drugs like corticosteroids, despite 
their potential pro-atrophic side effects, are the current standard of care for DMD. A big portion 
of current DMD therapy-related research focuses on intercepting the pathways implicated in 
fibrotic tissue formation, namely those triggered by TGF-β and Mstn (121).  
Interestingly, SC fate conversion from the myogenic to the fibrogenic lineage can contribute 
to fibrosis development in DMD. Thus, increased Wnt signaling in dystrophic muscle triggers 
TGF-β2 secretion, which in turn induces pro-fibrotic gene expression in SCs, thereby limiting 
their myogenic potential (122). Besides progressive fibrosis, the SC niche in DMD is affected 
by other events, such as alterations in the BL with differential expression of laminin α2, laminin 
β1 and collagen IV, which are implicated in the direct interactions with SCs (123), as well as 
that of decorin and biglycan, proteoglycans linked to TGF-β sequestration (124). These 
changes presumably also contribute to alterations in muscle stiffness, which further affects SC 
behavior. In addition, perturbed conditions can alter the differentiation of several multipotent 
progenitor populations in the muscle, including FAPs, resulting in extracellular fat 
accumulation (75). Of note, these alterations to the SC niche can be extrapolated to other 
dystrophies and muscle pathologies with prominent fibrosis and fat accumulation, even 
diseases such as type 2 diabetes (125, 126).  
The niche has been the primary focus of research on SC dysfunction in DMD, mainly due to a 
body of literature suggesting that dystrophin expression is limited to differentiated myofibers. 
However, recent findings suggests a direct role of SCs in the pathology based on the discovery 
that dystrophin is also expressed in activated SCs and is important for establishing cell polarity, 
thus enabling asymmetric SC division (127). Lack of SC dystrophin therefore results in reduced 
numbers of committed progenitors and differentiated myocytes, as well as a higher numbers of 
Myf5- progenitors. However, both increased and decreased SC numbers have been reported in 
DMD, a discrepancy that could be due to the difference in age of the subjects in the studies in 
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question (128, 129). Given the reciprocal regulation between SCs and fibroblasts (21), it will 
be interesting to further explore the role of SC dystrophin in fibrotic tissue accumulation and 
other DMD symptoms.  
Dysferlinopathy is another example of a muscular dystrophy with a complex etiology. In this 
disease, a mutation in the structural protein dysferlin primarily prevents myotubes from 
patching contraction-induced small ruptures in the sarcolemma. However, dysferlinopathy also 
affects proper muscle regeneration, where impairment in the release of cytokines upon injury 
results in reduced neutrophil recruitment and leads to a prolonged inflammatory phase, creating 
a suboptimal environment for successful regeneration by SCs (130).  
Despite extensive efforts, no treatment for most of these debilitating diseases has been found 
so far. Therapies are mainly symptomatic and palliative, relying on corticosteroids as well as 
pulmonary and cardiac management in the case of DMD (131). Experimental treatments 
centered on stem cell therapy (e.g. SC transplantation), gene therapy (e.g. antisense 
oligonucleotide exon skipping, viral delivery of mini-dystrophin, CRISPR/Cas9-mediated 
deletion) and pharmacology (e.g. Mstn blockade) might, however, result in therapeutic 
breakthroughs in the future (132-135).  
Future directions – an artificial niche 
Autologous SC therapy represents one of the most promising treatments both for dystrophies 
and sacropenia. In sacropenia, enhancement of the myogenic potential of SCs and expansion 
of bona fide SCs in vitro prior to their transplantation in order to boost regeneration would 
most likely be sufficient, while in dystrophic conditions, the approach would comprise stem 
cell and gene therapy, including correction of a relevant genetic mutation in vitro. However, 
several hurdles impede the success of such trials. For example, the inability of SCs to home in 
on muscle with systemic delivery (136), poor migration when delivered intramuscularly (137), 
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as well as reduced proliferation, immediate differentiation, and apoptosis of injected cells have 
been reported. These effects are further compounded by the rapid and irreversible loss of SC 
stemness in culture, resulting in reduced myogenic potential upon transplantation (138). Thus, 
as expanding the stem cell population is a necessary step prior to implantation, improving the 
intrinsic myogenic potential of SCs, e.g. by overexpressing PGC-1α, can help to lead to 
enhanced early muscle tissue formation after transplantation (139). Furthermore, attempts have 
been made to mimic the SC niche in vitro to circumvent some of the aforementioned problems.  
Bioengineering efforts have made progress in creating 3D biomimetics as acellular or cellular 
scaffolds for use in regenerative therapy (140). From cylindrically shaped, collagen I-based 
gels to various natural hydrogels and finally fibrin gels, conditions conductive to increasing 
cell survival, fusion and maturation are constantly improving (4). For example, in the case of 
trauma-induced volumetric muscle loss, acellular biodegradable materials filled with anti-
fibrotic and pro-myogenic factors on one, and angiogenic and neurotrophic factors on the other 
hand, would possibly provide optimal conditions to tip the balance towards functional muscle 
tissue instead of scar tissue formation when transplanted in a timely manner (141, 142). These 
scaffolds would provide not only fast infiltration and proper activation of the myogenic cells 
of the host, but also support fast establishment of the vascular and neural network necessary to 
support the newly formed muscle tissue. Other conditions such as aging and dystrophies 
require, however, more intricate cellular approaches, with biomaterials that closely resemble 
the satellite cell niche in terms of stiffness and composition, enabling the cell-matrix 
interactions that are crucial for proper SC function. In that regard, polyethylene glycol 
hydrogels cross-linked with laminin have been used successfully in improving satellite cell 
self-renewal in vitro and engraftment in vivo (93). This substrate, in combination with 
pharmacological inhibition of the p38α/β MAPK pathway, was also able to reverse the age-
related SC pathology (108).  
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Besides identification of ECM proteins as crucial components of an artificial niche, the search 
for extrinsic factors that would enable SC expansion in vitro without loss of cell stemness has 
led to the discovery of a cocktail of four cytokines. Intrigued by the role of CD4+ and CD8+ T 
cells in regeneration, Fu and colleagues identified T cell-derived factors that are responsible 
for increased SC proliferation. They defined a pro-inflammatory cytokine combination 
composed of IL-1α, IL-13, TNF-α and INF-γ that is sufficient and necessary to maintain SC 
potency in vitro (143). This combination of cytokines promoted proliferation and limited 
differentiation of SCs for 20 passages. The gene expression profile of cells expanded in this 
way suggests that these cells retain at least some of the features of freshly isolated SCs, such 
as high Pax7 and low MyoD expression. SCs expanded under such conditions were not only 
able to engraft efficiently and occupy the niche upon transplantation into muscle, but also to 
respond to secondary injury by undergoing activation and self-renewal (143). In addition, the 
transplantation efficiency of such expanded cells in vitro was comparable to freshly isolated 
SCs. Since the cocktail in question has been optimized for murine SCs, efforts will have to be 
made to find proper conditions and factors for human SCs. 
Recently, Quarta and colleagues successfully mimicked the in vivo microenvironment of SCs 
by using a defined serum-free quiescence medium and artificial muscle fibers. A 3D 
microscaffold with an elasticity between 1-2kPa based on collagen, recombinant laminin and 
α4β1 integrin provided optimal stiffness and enabled signaling pathways to keep the cells in 
reversible quiescence (144). This method proved effective in keeping both murine and human 
SCs in a quiescent state for up to a week. With this system, the engraftment potential and self-
renewal of cultured cells upon transplantation surpassed that of freshly isolated SCs and was 
comparable to SCs associated with their native fibers. These results confirm the importance of 
the niche and mimicking the in vivo microenvironment for maintaining SC stemness in vitro 
(144). 
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These studies provide crucial insights into the optimal conditions for keeping SCs in a 
quiescent state in vitro, SC propagation, and preservation of the stemness for subsequent in 
vivo transplantation. Importantly, an artificial niche not only enables disease modeling and 
gene therapy, but also provides an amenable experimental system for toxicology screenings of 
novel drugs, thereby reducing the burden of animal studies (145, 146). Together with novel 
imaging and cell tracking techniques (147), the increasing knowledge about SC biology, the 
importance of the niche, and the interplay of SCs with myofibers and other cell types will 
hopefully result in novel therapeutic approaches to treating sarcopenia, muscular dystrophies 
and other skeletal muscle-associated pathologies. 
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Figure Legends  Figure 1. The quiescent niche  Under homeostatic conditions, the SC and its niche are in a quiescent (q) state. The qSC receives signals that keep it dormant, such as angiopoietin 1 (Ang1) from periendothelial cells (PECs) and calcitonin (Calc) from the bloodstream, but at the same time actively contributes to the niche state by secreting protease inhibitors (Serpin, Tfpi2, Timpf4). The SC is attached with M-cadherin to the myofiber (MF) and with integrin to the basal lamina (BL). Fibro/adipogenic progenitors (FAPs) and macrophages (MAs) are present in low numbers and are mainly inactive. (EC – endothelial cell, FI – fibroblast, RL – reticular lamina, Calcr – calcitonin receptor, Tie-2 – receptor for Ang1)                            Figure 2. The activated niche  The damaged myofiber (dMF) changes the signaling balance in the niche and causes activation (a) of the SC by liberating hepatocyte growth factor (HGF). The aSC increases in size and begin secreting matrix metalloproteases (MMPs), as well as fibronectin, which together with Wnt7a supports SC proliferation through the Frizzled 7 and syndecan 4 receptors. The dMF expresses Delta and secretes Wnt7a, SDF-1 and growth factors (GFs) that further regulate SC behavior. GFs are also secreted by fibroblasts (FIs), endothelial cells (ECs) and are delivered by the bloodstream to the niche. In addition, cytokine secreting fibro/adipogenic progenitors (FAPs) and macrophages (MAs) increase in number.  The result is higher density of the basal lamina (BL) and reticular lamina (RL). (PEC – periendothelial cell, Notch – receptor for Delta, c-Met – receptor for HGF, CXCR4 – receptor for SDF-1)  Figure 3. The aged niche  The aged myofiber (agMF) has a smaller diameter, fewer myonuclei and reduced levels of Delta, a ligand of Notch, which is crucial to SC proliferation. Further changes to the niche include increased fibroblast numbers and a denser basal and reticular lamina (BL, RL) with reduced fibronectin levels, active macrophages (MAs) secreting TGF-β, as well as increased levels of FGF-2, IL-6 and Wnt signaling molecules. (PEC – periendothelial cell, EC – endothelial cell, FAP – fibro/adipogenic progenitor)  Figure 4. The dystrophic niche  The dystrophic fiber (dyMF) is smaller in diameter with centrally located nuclei, a hallmark of ongoing damage and regeneration. As a result, dySCs are under high proliferative pressure. Similar to the aged niche, elevated levels of TGF-β and Wnt, as well as increased numbers of fibroblasts (FIs), are common features of the dystrophic niche. In addition, inflammation caused by high numbers of fibro/adipogenic progenitors (FAPs) and macrophages (MAs) contributes to the formation of fat and scar tissue (a denser basal and reticular lamina – BL, RL) at the expense of muscle tissue. (PEC – periendothelial cell, EC – endothelial cell)  
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